BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
+7.64%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$6.56B
AUM Growth
+$19.4M
(+0.3%)
Cap. Flow
-$236M
Cap. Flow
% of AUM
-3.59%
Top 10 Holdings %
Top 10 Hldgs %
37.22%
Holding
183
New
22
Increased
65
Reduced
79
Closed
14
Top Buys
| 1 |
DexCom
DXCM
|
$42.5M |
| 2 |
SAGE
Sage Therapeutics
SAGE
|
$17.8M |
| 3 |
SI-BONE Inc
SIBN
|
$16.6M |
| 4 |
Steris
STE
|
$16.5M |
| 5 |
Beam Therapeutics
BEAM
|
$16.5M |
Top Sells
| 1 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
$114M |
| 2 |
Intuitive Surgical
ISRG
|
$59.8M |
| 3 |
Neurocrine Biosciences
NBIX
|
$51.7M |
| 4 |
Evolent Health
EVH
|
$29.3M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$28.3M |
Sector Composition
| 1 | Healthcare | 99.12% |
| 2 | Industrials | 0.77% |
| 3 | Technology | 0.02% |
| 4 | Communication Services | 0.02% |
| 5 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Regenxbio
RGNX
$498M
| $253K | ﹤0.01% |
+12,000
| New | +$253K |
|
152
MoonLake Immunotherapeutics
MLTX
$3.78B
| $221K | ﹤0.01% |
+4,400
| New | +$221K |
|
153
Baidu
BIDU
$33.1B
| $211K | ﹤0.01% |
+2,000
| New | +$211K |
|
|
AUTL
154
Autolus Therapeutics
AUTL
$383M
| $207K | ﹤0.01% |
32,500
-17,500
| -35% | -$112K |
|
155
Baxter International
BAX
$12.1B
| $180K | ﹤0.01% |
+4,200
| New | +$180K |
|
156
Viatris
VTRS
$12.3B
| $173K | ﹤0.01% |
14,515
-3,488
| -19% | -$41.6K |
|
157
89bio
ETNB
$1.37B
| $159K | ﹤0.01% |
13,700
-6,500
| -32% | -$75.7K |
|
158
IDEAYA Biosciences
IDYA
$2.26B
| $145K | ﹤0.01% |
+3,300
| New | +$145K |
|
159
Mineralys Therapeutics
MLYS
$1.94B
| $119K | ﹤0.01% |
+9,200
| New | +$119K |
|
160
NVIDIA
NVDA
$4.15T
| $87.6K | ﹤0.01% |
970
-20
| -2% | -$1.81K |
|
161
Qualcomm
QCOM
$170B
| $87.5K | ﹤0.01% |
517
+170
| +49% | +$28.8K |
|
162
Oracle
ORCL
$628B
| $85K | ﹤0.01% |
677
+223
| +49% | +$28K |
|
163
Agilent Technologies
A
$35.5B
| $78.6K | ﹤0.01% |
540
+177
| +49% | +$25.8K |
|
164
Microsoft
MSFT
$3.76T
| $75.7K | ﹤0.01% |
180
+58
| +48% | +$24.4K |
|
165
OmniAb
OABI
$219M
| $62.1K | ﹤0.01% |
+11,456
| New | +$62.1K |
|
166
Mettler-Toledo International
MTD
$26.1B
| $43.9K | ﹤0.01% |
33
+8
| +32% | +$10.7K |
|
167
Labcorp
LH
$22.8B
| $32.3K | ﹤0.01% |
148
-6,941
| -98% | -$1.52M |
|
|
EXAI
168
DELISTED
Exscientia Plc American Depositary Shares
EXAI
| $15.1K | ﹤0.01% |
2,644
+879
| +50% | +$5.03K |
|
169
IonQ
IONQ
$12.2B
| $11.1K | ﹤0.01% |
1,107
+366
| +49% | +$3.66K |
|
170
DaVita
DVA
$9.72B
| – | – |
-3,800
| Closed | -$398K |
|
171
VanEck Junior Gold Miners ETF
GDXJ
$6.91B
| – | – |
-5,000
| Closed | -$190K |
|
172
Kosmos Energy
KOS
$803M
| – | – |
-256,500
| Closed | -$1.72M |
|
173
Life Time Group Holdings
LTH
$6.11B
| – | – |
-25,200
| Closed | -$380K |
|
174
lululemon athletica
LULU
$23.8B
| – | – |
-770
| Closed | -$394K |
|
175
iShares MSCI China ETF
MCHI
$7.91B
| – | – |
-4,100
| Closed | -$167K |
|